Logo image of AVIR

ATEA PHARMACEUTICALS INC (AVIR) Stock Analyst Ratings

NASDAQ:AVIR - Nasdaq - US04683R1068 - Common Stock - Currency: USD

2.98  -0.01 (-0.33%)

After market: 2.98 0 (0%)

Buy % Consensus

50

ChartMill assigns a Buy % Consensus number of 50% to AVIR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.12. This target is 105.37% above the current price.
AVIR was analyzed by 8 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about AVIR.
In the previous month the buy percentage consensus was at a similar level.
AVIR was analyzed by 8 analysts. More opinions would make the average more meaningful.
AVIR Historical Analyst RatingsAVIR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -54 -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.986.066.126.126.30 - 103.36% 105.37% 105.37% 111.41%
AVIR Current Analyst RatingAVIR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-04-11 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-08-13 Morgan Stanley Upgrade Underweight -> Equal-Weight
2023-08-10 JP Morgan Downgrade Neutral -> Underweight
2023-03-16 JP Morgan Maintains Neutral
2023-01-27 SVB Leerink Maintains Market Perform
2023-01-24 Morgan Stanley Maintains Underweight
2022-08-15 Morgan Stanley Maintains Underweight
2022-03-02 JP Morgan Maintains Neutral
2022-03-01 SVB Leerink Maintains Market Perform
2022-02-16 SVB Leerink Maintains Market Perform
2022-01-06 Morgan Stanley Downgrade Equal-Weight -> Underweight
2021-11-18 SVB Leerink Downgrade Outperform -> Market Perform
2021-10-20 SVB Leerink Maintains Outperform
2021-10-20 JP Morgan Downgrade Overweight -> Neutral
2021-10-05 Morgan Stanley Downgrade Overweight -> Equal-Weight
2021-09-09 SVB Leerink Initiate Outperform
2021-08-18 Morgan Stanley Maintains Overweight
2021-06-03 Morgan Stanley Maintains Overweight
2021-04-06 Morgan Stanley Maintains Overweight